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Abstract
Background: Investigators have focused on mechano-regulation of upstream
signaling and responses at the level of gene transcription, protein translation and post-
translational modifications. Intracellular pathways including those involving integrin
signaling, mitogen activated protein kinases (MAPKs), and release of intracellular
calcium have been confirmed in several laboratories.
Studies with IGF-1: Insulin-like growth factor-I (IGF-1) is a potent anabolic
factor capable of endocrine and paracrine/autocrine signaling. Previous studies have
demonstrated that mechanical compression can regulate the action of IGF-1 on
chondrocyte biosynthesis in intact tissue; when applied simultaneously, these stimuli act
by distinct cell activation pathways. Our objectives were to elucidate the extent and
kinetics of the chondrocyte transcriptional response to combined IGF-1 and static
compression in cartilage explants. Discussion: Clustering analysis revealed five distinct
groups. TIMP-3 and ADAMTS-5, MMP-l and IGF-2, and IGF-1 and Collagen II, were
all robustly co-expressed under all conditions tested. In comparing gene expression
levels to previously measured aggrecan biosynthesis levels, aggrecan synthesis is shown
to be transcriptionally regulated by IGF- 1, whereas inhibition of aggrecan synthesis by
compression is not transcriptionally regulated. Conclusion: Many genes measured are
responsive the effects of IGF-1 under 0% compression and 50% compression. Clustering
analysis revealed strong co-expressed gene pairings. IGF-1 stimulates aggrecan
biosynthesis in a transcriptionally regulated manner, whereas compression inhibits
aggrecan synthesis in a manner not regulated by transcriptional activity.
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Chapter 1
Mechanobiology: Introduction, Background, and Significance*
* This chapter has appeared as a review paper in Current Opinions in Orthopaedics
(Wheeler, Cameron A; Fitzgerald, Jonathan B; Grodzinsky, Alan Cartilage
mechanobiology: the response of chondrocytes to mechanical force. Current Opinion
in Orthopedics. 16(5):346-353, October 2005.)
1.1 Purpose of the Review
A comprehensive understanding of chondrocyte mechanobiology is critically
important for a clear understanding of the etiopathology and treatment of osteoarthritis
(OA) as well as for the long-term survival of tissue engineered implants for cartilage
repair.
Recent Findings
A large body of evidence has emerged documenting the effects of various
mechanical loading modalities on chondrocyte biosynthesis and gene expression. Many
physical forces and flows occur in cartilage during loading in vivo. For example, dynamic
compression of cartilage results in deformation of cells and the extracellular matrix,
hydrostatic pressurization of the tissue fluid, pressure gradients and the accompanying
flow of fluid within the tissue, and streaming potentials and currents induced by fluid
convection of counter-ions through the negatively charged extracellular matrix (ECM). In
addition, local changes in tissue volume caused by compression also lead to alterations in
matrix water content, ECM fixed charge density, mobile ion concentrations, and osmotic
pressure. Any of these mechanical and physicochemical phenomena in the micro-
environment of chondrocytes may affect cellular metabolism. While specific components
of certain mechanotransduction pathways have been identified, the exact mechanisms by
which mechanical forces influence the biological activity of chondrocytes are not yet
fully understood. New genomic and proteomic technologies and methodologies including
systems biological analyses are being applied to better understand cellular
mechanotransduction.
Summary
Investigators have focused on mechano-regulation of upstream signaling and
responses at the level of gene transcription, protein translation and post-translational
modifications. Intracellular pathways including those involving integrin signaling,
mitogen activated protein kinases (MAPKs), and release of intracellular calcium have
been confirmed in several laboratories.
1.2 Introduction
Articular cartilage is an avascular, aneural, alymphatic tissue that provides a low
friction weight bearing surface for joint locomotion. During joint loading in vivo,
cartilage is subjected to mechanical stresses and strains that span a wide range of
amplitudes and frequencies [1, 2]. Peak stresses can reach 10-20 MPa (100-200 atm)
during activities such as stair climbing [3]. While compressive strains of 15% - 40% may
occur in response to long-term or "static" loads within the physiological range [1],
compressions of only a few percent occur during normal ambulation (e.g., the "dynamic"
strains that occur at walking frequencies of -1 Hz). Chondrocytes occupy 3% to 5% of
tissue volume in adult human cartilage [1]. These cells maintain a mechanically
functional extra-cellular matrix (ECM) by mediating the synthesis, assembly, and
degradation of proteoglycans (PGs), collagens, glycoproteins, and other matrix
molecules. It is well known that chondrocytes can sense and respond to their mechanical
environment; however, the mechanotransduction pathways by which mechanical forces
influence the biological activity of chondrocytes are not fully understood.
1.3 Systems for Studying Chondrocyte Mechanotransduction
Since mechanotransduction mechanisms are difficult to quantify in vivo, model
systems such as cartilage explant organ culture and three dimensional chondrocyte/gel
culture have been used. Cartilage explants preserve native tissue structure and cell-matrix
interactions and thereby enable quantitative correlations between mechanical loading
parameters and biological responses such as gene expression and biosynthesis. Muir [4]
emphasized the important but complex role of the native ECM and chondrocyte-ECM
interactions in chondrocyte response to load; thus, investigators [4] have cautioned that
the use of isolated, plated chondrocytes that are depleted of ECM must be approached
with care regarding the potential for chondrocyte dedifferentiation and the interpretation
of the results in relation to the behavior of cartilage. In native tissue, however, the
coupling between mechanical, chemical, and electrical forces and flows within the ECM
can complicate the identification of specific physical stimuli, necessitating specialized
experimental and theoretical modeling approaches. Therefore, three-dimensional agarose
[5], alginate [6], and other scaffold culture systems have also been used to study
chondrocyte response to mechanical compression[7-9], hydrostatic pressure [10], stretch
[11 ], physicochemical stimuli (pH and osmolarity [12], and electrical currents [13]).
Finally, a variety of specialized, incubator-housed instruments have been developed to
mimic mechanical stimuli found in vivo and apply components of compression, shear,
stretching, hydrostatic or osmotic pressure to explants, isolated cells, or cell-encapsulated
gel constructs in vitro [14-17], shown schematically in Fig. 1.1.
1.4 Chondrocyte biosynthesis and gene expression
Static compression (Fig. 1.1 a) of animal and human cartilage explants [18, 19] as
well as high hydrostatic pressure applied to chondrocyte monolayers [20] can cause a
dose-dependent decrease in the biosynthesis of proteoglycans, collagens, and other ECM
proteins as quickly as one hour after application of compression. Complete recovery of
biosynthesis can occur after release of compression, but at different rates for different
ECM macromolecules [21], strongly suggesting that specific transduction pathways are
involved. In contrast, dynamic compression and shear (Fig 1.1 b,c) [18, 22, 23] and cyclic
hydrostatic compression [20, 24] can markedly upregulate ECM biosynthesis in a manner
dependent on compression amplitude and frequency [20, 22], as well as the
developmental stage and the depth from the articular surface of the cartilage sample [14,
25, 26]. Tissue-level and cell-level quantitative autoradiography have been used to
visualize the spatial distribution of newly-synthesized ECM molecules in response to
compression and shear [23, 27, 28], and to compare with the theoretically predicted
profiles of physical stimuli, highlighting the roles of ECM and cell deformation as well as
intratissue fluid flow (shown schematically in Fig. 1.1).
Mechanical forces can also influence aggrecan gene expression [29-33] and the
transcription of many matrix proteins and proteases in chondrocytes and other connective
tissue cells [33-36]. Investigators have also found thatfluid shearflow [37-40] can alter
aggrecan synthesis and the expression of aggrecan, TIMP-1, IL-6 and MMP-9. The
induction of MMP-9 gene expression appeared to be mediated via the JNK signaling
pathway [38], and the aggrecan promoter via the ERK pathway [39]. While the fluid
velocities in these experiments were much higher than physiological for cartilage, the
resulting shear stresses may be relevant. When isolated bovine and human chondrocytes
were cyclically stretched on flexible membranes, aggrecan and type II collagen mRNA
expression were increased [40], consistent with a role for cell deformation and membrane
perturbation. Cyclic (1 Hz square wave) uniaxial stretch (5% elongation) of embryonic
chick sternal chondrocytes seeded into a 3D collagen sponge induced expression of
Indian hedgehog (Ihh) and also upregulated bone morphogenic proteins 2 and 4
downstream of Ihh which, in combination, stimulated cell proliferation [11].
Interestingly, mechanical induction of Ihh mRNA was abolished by blocking stretch
activated channels [11].
1.5 Upstream Signaling
Investigators have been trying to map the sequential intracellular signaling pathways
through which mechanical forces can modify the gene expression of specific molecules.
Major roles have been identified for certain classical signaling pathways including those
involving integrins, mitogen activated protein kinases (MAPKs), and release of
intracellular calcium.
Integrin signaling pathways
Evidence suggests that integrins can convert extracellular mechanical stimuli into
intracellular signals in a variety of cell types [41]. In chondrocytes, the alpha a5Pf
fibronectin-binding integrins have been implicated as part of a mechanotransduction
complex that involves tyrosine protein kinases, cytoskeletal proteins, ion channels, and
second-messenger signaling cascades [42, 43]. Researchers have also shown that the
a53l integrin complex is present in OA chondrocytes, but results in different downstream
effects when activated or blocked compared to normal chondrocytes [44]. Application of
hydrostatic pressure to chondrocyte monolayers in a manner that induced strain on the
culture dish and plated cells caused interleukin-4 (IL-4) secretion via a5p1 integrin and
subsequent intracellular calcium release followed by cell hyperpolarization [42, 45]. One
possible connecting link is the N-methyl-D-aspartate (NMDA) receptor, since integrin
signaling has been shown to influence the activity of this receptor in other cells [46].
NMDA is phosphorylated by protein kinases including protein kinase C (PKC) and
phosphotidylinositol 3-kinase (PI3K) [47]. Salter el al. observed that the NMDA receptor
induced depolarization in OA chondrocytes and hyperpolarization in normal
chondrocytes, suggesting a possible alteration in chondrocytic mechanotransduction as a
consequence of the function of the NMDA receptor during OA [48].
Mitogen activated protein kinase pathways
Investigators have been trying to map the sequential intracellular signaling
pathways through which mechanical forces may modify chondrocyte gene expression of
specific molecules. Several recent studies have demonstrated a role for mitogen activated
protein kinases (MAPKs) [49, 50] which can alter matrix gene expression and changes in
matrix production by chondrocytes within compressed cartilage and in chondrocyte
monolayers [51]. This family of ubiquitous signaling molecules includes extracellular-
signal regulated protein kinases (ERKl/2), c-Jun N-terminal kinase (JNK) and p38.
Activated MAP kinases are thought to translocate to the nucleus, where they may induce
phosphorylation of transcriptional factors and eventual upregulation of various genes.
Fanning et al. [52] examined the effects of slow ramp-and-hold compression of cartilage
explants to final static strains up to 50% that were held for a range of compression
durations; these compression conditions were found previously to inhibit chondrocyte
biosynthesis but not to affect cell viability. Mechanical compression caused (1) a rapid
induction of ERK1/2 phosphorylation at 10 min followed by a rapid decay, as well as a
sustained level of ERK2 phosphorylation that persisted for at least 24 hrs; (2)
phosphorylation of p38 in strictly a transient fashion, with maximal phosphorylation
occurring at 10 min; and (3) stimulation of SEK1 phosphorylation with a maximum at the
relatively delayed time point of lhr and with a higher amplitude than ERK1/2 and p38
phosphorylation. (SEKI is an immediate upstream specific activator of JNKs 1,2 and 3
[53], and the JNK and p38 kinases together constitute the SAPK sub-family of MAPKs
[54]). Fanning et al. [50] proposed that the rapid activation of ERKl/2 and p38 may be
due to the cell deformation, fluid flow and pressurization, while the SEK1 pathway was
activated only under static compression without fluid flow or pressurization [50]. Thus,
it was suggested that the initial transient ERK1/2 response was due to the dynamic
components of static compression, consistent with the results of Li et al. [49], who found
a significant upregulation of ERKl/2 activation in response to dynamic compression.
ATP and Ca2+
Ion channels have been identified as another important factor in
mechanotransduction, including effects of cell stretching on chondrocyte
hyperpolarization and depolarization [55]. ATP has been shown to be involved in
signaling in many cell types. Under compressive conditions, bovine chondrocytes can
release ATP [56, 57] which, in the extracellular space, can then bind to membrane
receptors and initiate a signaling cascade including stimulation of an increase in
proteoglycan synthesis [58]. While ATP can induce anabolic signaling in normal
chondrocytes, OA chondrocytes do not show upregulation of matrix production.
Mechanical stimulation can also increase the concentration of intracellular calcium ions,
derived either from intracellular stores or from the extracellular space and transported
into the cell via stretch activated ion channels. While hyperosmotic stress can initiate
intracellular Ca2+ signaling in chondrocytes [59], Erickson et al. demonstrated that the
stretch activated ion channels were not necessarily responsible for Ca2+ transients under
these conditions. Cell volume was also shown to decrease under hyperosmotic stress
and, hence, the stretch effect was explained by an inhomogeneity in the cell surface [59].
The role of intracellular calcium in native cartilage explants was studied by Vahlmu and
Raia [60]; using blockers of intracellular Ca2+ and protein kinase C, they demonstrated
that regulation of aggrecan mRNA levels under creep compression involved
Ca2+/calmodulin and myo-inositol 1,4,5-triphosphate signaling processes. Fitzgerald et al.
also found that compression of cartilage explants induces multiple time-dependent gene
expression patterns that involve intracellular calcium and cyclic AMP [61].
1.6 Pro-inflammatory pathways in normal and injurious
compression
Acute traumatic joint injury increases the risk for subsequent development of OA
[62]. In order to quantify the events following cartilage and joint injury, investigators
have turned to a variety of in vitro and animal models. Studies have shown that threshold
levels of compressive strain, strain rate, and peak stress can cause cartilage matrix
disruption, tissue swelling, cell necrosis and apoptosis, and increased loss of matrix
macromolecules [63-70]. As a baseline control for changes in gene expression in bovine
calf cartilage explants, mRNA levels measured in non-injured free swelling tissue was
found to vary over five orders of magnitude, with matrix molecules being the most highly
expressed of the genes tested and cytokines, matrix metalloproteinases (MMPs),
aggrecanases (ADAMTSs), and transcription factors showing lower levels of expression
[71]. While the matrix molecules showed little change in expression after injurious
compression, MMP-3 increased -250-fold, ADAMTS-5 increased -40-fold, and TIMP-1
increased -12-fold over free swelling levels [66]. In addition, injurious compression
results in a decrease in biosynthetic rates in the remaining viable cells, and these viable
cells no longer respond to the stimulatory effects of moderate dynamic compression seen
in normal cartilage [70]. Taken together, these studies suggest that mechanical overload
can cause long-term cell mediated changes in matrix quality and turnover.
Deschner et al. recently summarized the interaction between loading and inflammatory
pathways [72], which may be activated by excessive loads and inhibited by moderate
cyclical loading [42, 45, 73]. Thus, these interactions appear to depend on the magnitude
and loading rate (frequency). Mechanical forces can influence production of NO [ 16, 74,
75], PGE2 [37], and IL-6 [76]. Interestingly, cross-talk between NO and PGE2 pro-
inflammatory pathways, and between NOS2 and COX2 (upstream of NO and PGE2), can
be regulated by mechanical stimuli [77]. These pathways have been traditionally
associated with inflammatory cytokines such as IL-1, an initiator of cartilage degradation
[42, 45, 73, 78-80]. Dynamic compression (15% strain amplitude, 1Hz, 48 hr) could
inhibit NO synthesis by equine chondrocytes in agarose gel constructs [81] ,and could
inhibit NO and PGE2 release by superficial zone equine chondrocytes stimulated by IL-
13 [82].
Cell microenvironment and organelle morphology
Loading of cartilage (Fig. 1.2a) produces cellular deformation [83, 84] in
proportion to the local deformation of the ECM, and in a manner consistent with the
depth-dependent compressive properties of the bulk tissue [85]. Deformations within the
pericellular matrix (Fig. 1.2b) also affect the physicochemical microenvironment of the
chondrocyte [28, 86] and may, in turn, signal the cell to modulate its biosynthetic
response. Deformation-induced fluid flow in the pericellular region enhances transport of
soluble factors to cell receptors, and alters the local concentration of mobile ions leading
to electrochemical changes such as shifts in pH[87]. Cell-surface connections to the ECM
enable pericellular deformations to be transmitted through the cell membrane to
intracellular organelles via cytoskeletal elements such as actin microfilaments,
microtubules, and intermediate filaments[20, 83, 88]. Compression can also dramatically
affect the morphology of intracellular organelles that regulate cell biosynthesis and
metabolism by altering gene transcription, intracellular transport and trafficking, and
protein translation and post-translational processing. Using chemical fixation, high-
pressure freezing, and electron microscopy, Szafranski et al. [89] observed that
compression of bovine cartilage explants caused a concomitant reduction in the volume
of the extracellular matrix, chondrocyte, nucleus, rough endoplasmic reticulum, and
mitochondria. Interestingly, however, the Golgi apparatus was able to resist loss of
intraorganelle water and retain a portion of its volume relative to the remainder of the
cell. These combined results suggested the hypothesis that organelle volume changes
were driven mainly by osmotic interactions while shape changes were mediated by
structural factors, such as cytoskeletal interactions that may be linked to extracellular
matrix deformations. The observed volume and shape changes of the chondrocyte
organelles and the differential behavior between organelles during tissue compression
provides evidence for an important mechanotransduction pathway linking translational
and post-translational events. For example, since the Golgi is the site of post-translational
modifications of aggrecan (e.g., glycosylation and sulfation) [89, 90], changes in Golgi
morphology and function with compression may play a critical role in the known changes
in GAG chain length and sulfation caused by compression [21]. Such changes in GAG
and aggrecan structure, which also occur naturally with age (Fig. 1.2c) may profoundly
influence aggrecan function. Such functional mechanical changes can now be measured
directly using atomic force microscopy methodologies [91, 92] (Fig. 1.2d).
1.7 Systems biology approaches
Real time PCR and gene clustering analyses have been used to study
intermediate-size gene sets thought to be involved with cartilage mechanotransduction.
Fitzgerald et al. [33] examined the kinetics of mechano-regulation of gene transcription
in response to static compression of bovine calf cartilage explants for periods between 1-
24 hours in the presence or absence of an intracellular calcium chelator or an inhibitor of
cyclic AMP activated protein kinase A. Cluster analysis of the data revealed four main
expression patterns: two groups that contained either transiently upregulated or duration-
enhanced expression profiles could each be subdivided into genes that did or did not
require intracellular calcium release and cyclic AMP activated protein kinase A for their
mechano-regulation. Transcription levels for aggrecan, type II collagen, and link protein
were upregulated approximately 2 to 3-fold during the first 8 hrs of 50% compression and
subsequently down-regulated to levels below that of free-swelling controls by 24hrs.
Transcription levels of matrix metalloproteinases-3,9,13, aggrecanase-1 and the matrix
protease regulator cyclooxygenase-2 increased with the duration of 50% compression 2
to 16-fold up to by 24 hrs. Thus, transcription of proteins involved in matrix remodeling
and catabolism dominated over anabolic matrix proteins as the duration of static
compression increased. These approaches are also being used to study responses to
dynamic compression and tissue shear of cartilage explants.
Researchers have begun to integrate genomic and proteomic approaches with the
computational tools of systems biology for applications in musculoskeletal research,
including medical diagnostics, and drug discovery [93]. DNA microarray technology is
being used to explore the complex feedback loops in transcription factors and layered
signaling pathways underlying the mechanotransduction as well as the pathobiology of
osteoarthritis. Aigner et al. [94-96] examined transcript levels of matrix components and
matrix degrading proteinases using DNA arrays. By comparing normal chondrocytes
with early and late stage OA chondrocytes, they examined expression trends involving up
and down regulation of MMPs, TIMPS, proteoglycans, and collagens [96]. Such
approaches can be directly applied to the study of mechanotransduction. While DNA
arrays can sample large numbers of genes, they are limited in their sensitivity and they do
not measure posttranscriptional regulation or modifications [94]. While recognizing these
limitations, the potential of such profiling approaches is clear [95, 97], since the results
can be used to formulate hypotheses about specific molecules and mechanisms in ways
that are complementary to the traditional one-gene or one-protein hypothesis-testing
approach.
1.8 Conclusion
Chondrocytes can sense and respond to mechanical forces in an extraordinarily
sensitive and robust manner. These cells can distinguish between compression, tension
and shear deformation of the surrounding ECM, and respond in a manner that varies with
the rate (frequency) of loading. Recent studies have identified several intracellular
signaling pathways that are involved in chondrocyte mechanotransduction and the
regulation of cartilage and exhibit levels of overlap or crosstalk in their signaling. These
complex signals are responsible for activation of ECM molecules proteinases,
inflammatory factors, and regulatory proteins which govern tissue homeostasis.
Significant technical advances have enabled the study of transduction mechanisms by
chondrocytes within their native, dense ECM. Advanced genomic and proteomic
technologies should lead to a further rapid increase understanding the fundamental link
between chondrocyte mechanobiology, physiology, and tissue homeostatis in health and
disease, with direct application to cartilage repair and tissue engineering.
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Figure 1.1: Schematic of physical forces and flows occurring during mechanical loading
of cartilage in vivo, that can be stimulated in vitro by means of (a) static compression, (b)
dynamic compression, and (c) dynamic tissue shear.
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Figure 1.2 : Loading of cartilage explants (a), or direct mechanical stimulation of cells
(b) can produce mechanical stimuli that may be sensed by the cell and its pericellular
microenvironment (b). These mechanical stimuli may alter the rate of synthesis as well as
the molecular structure of ECM molecules such as aggrecan (c) which, in turn, could
ultimately affect tissue-level biomechanical properties in a feedback fashion (a). New
cell-level and molecular-level measurement techniques, such as those based on atomic
force microscopy, are being used to quantify the molecular mechanical properties of
ECM macromolecules (d) as well as cellular mechanical properties (b).
(a)
Chapter 2
TRANSCRIPTIONAL EFFECTS OF COMBINED MECHANICAL
COMPRESSION AND IGF-1 STIMULATION ON BOVINE CARTILAGE
EXPLANTS*
* This chapter is in preparation for submission to the Journal of Orthopaedics Research
(Wheeler, Cameron A and Grodzinsky, Alan J.)
2.1 Abstract
Introduction: Insulin-like growth factor-i (IGF-1) is a potent anabolic factor capable of
endocrine and paracrine/autocrine signaling. Numerous studies have shown that
chondrocytes produce this important growth factor, and that IGF-1 can stimulate ECM
biosynthesis by chondrocytes in native cartilage and tissue engineered constructs.
Previous studies have demonstrated that mechanical compression can regulate the action
of IGF-1 on chondrocyte biosynthesis in intact tissue; when applied simultaneously, these
stimuli act by distinct cell activation pathways. Our objectives were to elucidate the
extent and kinetics of the chondrocyte transcriptional response to combined IGF-1 and
static compression in cartilage explants. Methods: Cartilage explants were harvested as
performed previously in our lab. Cartilage plugs were placed in 50% compression and
0% compression with or without 300 ng/ml of IGF-1. RNA was obtained and measured
by real-time PCR for 2, 8, 24, 32, 48 hours after treatment and compression.
Results and Discussion: Transcript levels in response to compression alone agreed with
previously published data. Key matrix molecules, aggrecan and collagen II, responded
positively to the addition of IGF-1 without compression, but this effect was abrogated
when compression was applied in combination with IGF-1 treatment. Clustering analysis
revealed five distinct groups. TIMP-3 and ADAMTS-5, MMP-1 and IGF-2, and IGF-1
and Collagen II, were all robustly co-expressed under all conditions tested. These co-
expressed molecules suggest inherent regulation and positive feedback in chondrocyte
gene expression. In comparing gene expression levels to previously measured aggrecan
biosynthesis levels, aggrecan synthesis is shown to be transcriptionally regulated by IGF-
1, whereas inhibition of aggrecan synthesis by compression is not transcriptionally
regulated.
Conclusion: Many genes measured are responsive the effects of IGF-1 under 0%
compression and 50% compression. Clustering analysis revealed strong co-expressed
gene pairings. IGF-1 stimulates aggrecan biosynthesis in a transcriptionally regulated
manner, whereas compression inhibits aggrecan synthesis in a manner not regulated by
transcriptional activity.
2.2 Introduction:
Insulin-like growth factor-i (IGF-1) is a 7.6 kDa, 8.5 PI, potent anabolic factor
capable of endocrine and paracrine/autocrine signaling. While IGF-1 is primarily
produced in the liver and transported throughout the body via the blood stream, numerous
studies have shown that chondrocytes produce this important growth factor, and that IGF-
1 can stimulate ECM biosynthesis by chondrocytes in native cartilage and tissue
engineered constructs. The use of growth factors as therapeutics to reverse or inhibit
cartilage degradation has been an underlying focus in cartilage research. The avascular,
alymphatic, and aneural nature of cartilage suggests that the growth factor be
administered though means of local delivery. Local delivery is complicated due to joint
motion and cartilage structure which affects special and temporal diffusion rates.
To investigate the effects of exogenous IGF-1, many studies have examined how
chondrocytes respond at the protein level as well as the gene transcript level. General
protein levels have been measured using conventional radiolabel incorporation (35S, 3H),
and show that chondrocytes respond in a dose dependent manner to IGF-1 [1-6]. The
environment the chondrocytes are cultured in varies (explants, gels, monolayer), but
generally chondrocyte biosynthesis levels are increased from 150% [4] to 2-6 fold
control levels [3, 6-8]. Researchers have also examined particular proteins using western
blot analysis. For example, MMP-13 was found to be suppressed in response to IGF-I
treatment [9]. When examining the transcript or gene levels in response to IGF-1,
researchers have focused on specific molecules using real-time PCR and reverse
transcription PCR. Type II collagen was shown in multiple studies to be significantly
upregulated by IGF-1 [3, 10-12]. Aggrecan transcripts have shown no significant
increase [3, 4] or slight upregulation [12] with the addition of IGF-1 in the first 48 hours
of IGF-1 treatment, yet were significant upregulation (130%) when treated for 1-3 weeks
[10]. IGF-1 transcript levels were shown to peak at 24 hours after IGF-1 treatment,
suggesting that IGF- 1 has an autocrine response [1]. Sox-9, a transcription factor was
also shown to have no significant response to IGF- 1 [11].
Chondrocytes have been shown to be responsive to mechanical compression on
both the protein and gene transcript levels. Static compression in vitro has been shown to
decrease protein biosynthesis levels of type II collagen and proteoglycans in a dose
dependent manner [5, 13]. In alginate and type I collagen gels seeded with chondrocytes,
50% static compression was shown to decrease radiolabel incorporation by nearly half in
comparison to non-compressed controls [14, 15]. Similar findings have been shown in
cartilage explants with proteoglycan and type II collagen synthesis decreasing within 1-2
hours of loading and remaining suppressed for the loading period (24 hrs) [16, 17].
When transcript levels were examined in response to static loading, type II collagen and
aggrecan were shown to initially peak anywhere from 1 to 4 hours after compression,
followed by a decrease to unaffected level of gene expression [13, 15, 18, 19]. Fitzgerald
et al. have investigated 28 different ECM related molecules including matrix proteinases,
tissue inhibitors of matrix metalloproteinases (TIMPs), growth factors, cytokines, and
structural ECM molecules, under static compression for a 24 hour period and reported 4
distinct patterns associate with gene expression [19].
Bonassar et al. have examined the combination of IGF-1 treatment with static
compression at a protein level and found when cartilage explants were treated with IGF-1
under 0% compression (cut thickness) a 2-3 fold increase was found over 48 hour [5].
Under static compression biosynthesis was decrease by 50% compared to non-
compressed conditions. When compressed explants were treated with IGF-1,
biosynthesis rates significantly increased, returning to levels comparable to non-
compressed, non-treated explants. Thus compression diminished the effects of IGF-1,
but did not altogether eliminate them. IGF-I was still able to upregulate or rescues the
synthesis rate of statically compressed cartilage explants.
Chondrocyte gene expression under a combination of IGF-1 treatment and static
compression have not been examined thoroughly. Our objectives were to elucidate the
extent and kinetics of the chondrocyte transcriptional response to combined IGF-1 and
static compression in cartilage explants.
2.3 Methods:
Cartilage Harvest, Mechanical Loading, and Growth Factor Treatment:
Cartilage-bone plugs were harvested from the patello-femoral groove of 1-2 week old
calves. Cartilage disks (1mm thick X 3mm diameter) were cored and punch from the
middle zone as described previously [20] and equilibrated for two days under free-swell
conditions in the presence of serum-free feeding medium consisting of high glucose
Dulbecco's modified essential medium supplemented with 10 nM Hepes Buffer, 0.1 mM
nonessential amino acids, 20 jig/ml ascorbate, 100 units/ml penicillin, 100 gg/ml
streptomycin, and 0.25 jig/ml amphoericin B. Five anatomically matched disks were
separated for each time point (Figure 2.1), and placed in polysulfone loading chambers.
Each time point consisted of four separate experiments. With cartilage disks matched
for time, 8 disks were allocated to 0% compression (i.e., compressed to 1-mm cut
thickness from free swelling), 50% compression, 0% compression + 300 ng/ml IGF-1,
and 50% compression + 300 ng/ml IGF-1, the IGF-1 concentration found previously to
maximally stimulate similar free-swelling calf cartilage explants [5]. At time zero, all
chambers were slowly compressed to specified strains over a 3 minute period to avoid
injurious effects of high strain rates. These strains were maintained for each of the four
conditions for 2, 8, 24, 32, and 48 hours (Figure 2.1). Upon completion of loading time,
disks were promptly removed, flash frozen in liquid nitrogen, and stored at -80o C.
RNA Extraction and Quantization, Primer Design, and Real-Time PCR: 8 disks
for each time point and condition were taken from -80o C freezer and pulverized. In
order to prevent RNA degradation, the pulverizing apparatus was constantly cooled using
liquid nitrogen. Once samples had been pulverized, Trizol (sigma, st. Louis) was added
and homogenized to thoroughly break down the tissue. After chloroform was added, the
mixture was transferred to pre-spun phase gel tubes, and spun at 13,000 rpm for 10
minutes at 40 C. Supernatant was removed, and RNA was extracted using Qiagen
RNAeasy mini kit protocol with recommended DNase digest (Qiagen). RNA was stored
in 50 gl of RNase free water under -80o C conditions. RNA quality and amount was
quantified by using NanoDrop ND-1000 spectrophotometer. According to RNA
measurements, 1 jg of RNA was reverse transcribed using Applied Biosystems reagents
as previously described [21]. Forward and reverse primers for 24 relent genes (Table 2.1)
were designed based on bovine genomic sequences and standard curves were calculated
as previously described [19]. Once cDNA was obtained, Real-Time PCR was performed
using MJResearch Opticon2 instrument and SYBR Green Master Mix (SGMM, Applied
Biosystems). SGMM was combined with RNase free water and cDNA and aliquated into
MJResearch 96-well plate. Using a multi-pipette, a premixed solution of forward and
reverse primer for 24 different genes was added to each well. Measured threshold values
(Ct) were converted to RNA copy number according to previously calculated standard
curves.
Data Normalization and Statistical Analysis: Under each loading condition and
time point, each gene RNA copy number was normalized to the 18s housekeeping gene
from that same condition and time point [22]. To examine the time course of gene
expression, 0% compression + IGF-1, 50% compression, and 50% compression + IGF-1
were normalized to 0% compression levels. Thus, if a gene expression value was below
or above 1, it represented a decrease or increase of gene expression respectively
compared to 0% compression. Expression levels due to experimental error were
removed. To assign statistical significance to expression levels, a non-parametric test
was used to ensure unbiased results by avoiding the assumption of a parameter based
distribution. The Wilcoxon sign ranked test was used to judge significance which
incorporates the amount of data in the significance statistic. Significance was assigned if
the Wilcoxon sign ranked test statistic produced a p-value less than 0.07. The minimum
p-value using the Wilcoxon sign ranked test is 0.068 due to the fact that there are only
four replicates. Thus, significance of 0.07 was chosen because with this non-parametric
test and amount of data, 0.05 cannot be obtained.
Clustering Analysis: In order to understand general transcriptional patterns in the
data, clustering analysis was performed on all normalized conditions (0% compression +
IGF-1, 50% compression, and 50% compression + IGF-1) and time points (2, 8, 24, 32,
48 hours) over 23 genes. This resulted in a 15 x 23 matrix which was standardized by
expression amplitude as described previously [19], in order to accentuate gene expression
patterns as appose to expression magnitudes. The 15 gene expression array vectors were
clustered using k-means clustering. Principle component analysis (PCA) was used to
determine the components that contain the greatest variance in the expression data[23,
24]. Once the 15 principle components had been calculated, the k-means clustering
algorithm was applied to the 15 principle components and clustered into k groups. The
average and variance of each projected coordinate group was calculated to compose a
group centroid. Centroid vectors were formed by combining the three main principal
components weighted by their projected centroid coordinate. The uniqueness of each
Group's expression patterns were evaluated by the Wilcoxon sign ranked test.
2.4 Results:
Effects of static compression: Cartilage disks were subject to 2, 8, 24, 32, and 48
hours of compression applied in a ramp and hold fashion. The disks experience a peak
stress when the compression is applied, followed by a slow stress relaxation due to the
poroelastic properties of cartilage. The five time points were chosen to capture the
kinetics of gene expression in repose to the changes in stress. Twenty-four different
genes were measured at each one of the five time points and were normalized to 18s, a
housekeeping gene, and 0% compression with no added IGF-1 was used as a control. 8
of the 23 genes measured were up-regulated for 3 or more of the time points examined.
These included ADAM-TS5, MMP-13, MMP-3, TGF-3, c-Fos, c-Jun, and Sox-9 (Figure
2.2, Appendix A). Matrix metalloproteinase- 3 (MMP-3) was significantly up-regulated
at 8, 24, 32, and 48 hours with a peak expression level of 30-fold compared to control at
32 hours (Figure 2.2A). ADAM-TS5 and MMP-13 displayed a transient increase in
expression levels peaking at 48 hours with >6-fold and >17-fold up-regulation
respectively (Figure 2.2B, Appendix A). TGF-f was consistently up-regulated 2.5-fold
from 8 hours to 32 hours (Figure 2.2D). Supporting previously reported data[19], c-Fos
and c-Jun were significantly up-regulated in response to 50% static compression at all
time points measured (Appendix A). Interestingly, c-Fos, c-Jun and Sox-9 were all
maximized at 8 hours (23-fold, 30-fold, and 6.8-fold respectively) (Appendix A).
Displaying a transient decrease, IGF-1 was the only gene measured that showed a
significant down-regulation in the presence of 50% strain for at least 3 of the measured
time points. IGF-1 was significantly down-regulated by 50% at 24 hours and up to 70%
at 48 hours (Appendix A).
Effects of GF-1: To examine the effect of IGF-1 on cartilage explants, disks
were incubated for 2, 8, 24, 32, and 48 hours with 300 ng/mL IGF-1 under 0%
compression. 10 of the 23 genes were upregulated with the treatment of IGF-1. IGF-1
up-regulated for three or more time points, MMP-13, MMP-1, TNF-x, and IL-1 3, which
traditionally are thought to play catabolic roles in cartilage. MMP-13, TNF-a, and IL-1P
were significantly up-regulated and peaked at 24 hours to the level of 8-fold, 2.5-fold,
and 2.75-fold respectively (Figure 2.2B and Appendix A). MMP-1 and IGF2 were
transiently up-regulated to a significant level until a 32 hour peak (4.75-fold and 3-fold
respectively), after which expression levels returned to control (Figure 2.21, 2.2E). Link
and Aggrecan were also transiently up-regulated with a peak of 32 hours (4-fold and 2.5-
fold respectively), but expression levels at 48 hours were still significantly above control
(Figure 2.2F, 2.2G). As in 50% static compression, Sox-9 was significantly up-regulated
at 8 hours to a comparable level of 6.3-fold (Appendix A). TIMP-3 and HSP90 were
significantly upregulated with for all time points and both displayed an initial peak of
expression (5-fold and 3-fold respectively), followed by a transient decrease of
expression over time (Figure 2.2C, Appendix A). No genes measured were significantly
down-regulated by the treatment of IGF-1.
Effects ofIGF-1 and static compression: Combining the treatment of 300 ng/mL
of IGF-1 and static compression to a level of 50% strain, 11 of the 23 genes were
significantly different than the 0% control for 3 or more time points. MMP-13, MMP-3,
TGF-j, c-Fos, c-Jun, TIMP-3, and HSP90 were significantly up-regulated in at least 3 of
the measured time points. MMP-13 and MMP-3 were significantly upregulated 4 out of
the 5 time points and had peak values of 28-fold and 33-fold respectively at 24 hours
(Figure 2.2B, 2.2A). TGF-f3 and HSP90 were transiently upregulated to a peak level of
3.8-fold and 2.25-fold respectively, at 32 hours (Figure 2.2D, Appendix A). c-Fos and c-
Jun were again significantly up-regulated for all time points with expression peaks at 24
and 8 hours (Appendix A). The peak value of c-Fos, 22-fold, was similar to the
expression levels found in 50% static compression alone. Alternatively, the peak value
of c-Jun had decreased from 30-fold under 50% static compression to 16-fold under 50%
static compression with IGF-1. TIMP-3 showed a slow increase of expression which
peaked at 24 hours to a level of 19-fold, followed by an up-regulated level of 10-fold
(Figure 2.2C). Co12, IGF-2, TIMP-2, and Txnip were significantly down-regulated for 3
or more time points measured. IGF-2 and Txnip showed a transient decrease of
expression over time and bottomed out at 48 hours decreasing 45% and 52% expression
below control (Figure 2.2E, Appendix A). Co12 and TIMP-2 were drastically decreased
under 50% static compression with IGF-1. Co12 was transiently down-regulated,
decreasing expression levels by 43% at 24 hours, to 62% at 48 hours (Figure 2.2H).
TIMP-2 was also transiently down-regulated, decreasing expression levels by 50% at 24
hours and 92% at 48 hours (Appendix A).
Comparing effects of IGF-1 under 0% and 50% compression: To elucidate the
different effects of IGF- 1, the effects of IGF- 1 were isolated by normalized gene
expression to like loading conditions. 50% static compression with IGF-1 was
normalized by 50% static compression, and 0% static compression with IGF-1 was
normalized to 0% static compression. When examining the effects of IGF-1 under non-
loaded conditions (0% static compression), 9 of the 23 genes were significantly altered
for 3 or more time points by the addition of IGF-1. Under loading conditions (50% static
compression), 4 of the 23 genes were significantly altered for 3 or more time points by
the addition of IGF-1 (Appendix B). Of the significantly affected genes, aggrecan, IGF-
2, and TIMP-3 were significantly affected by IGF-1 in both loaded and un-loaded
conditions (Figure 2.3). Aggrecan, IGF-2, and Link were all up-regulated when treated
with IGF-1 under un-loaded conditions, and down-regulated when treated with IGF-1
under loaded conditions (Figure 2.3A, 2.3B, 2.3C). Aggrecan in particular was
significantly up-regulated for all time points by IGF-1 under un-loaded conditions, and
significantly down-regulated for all time points by IGF-1 under loaded conditions (Figure
2.3A). In contrast, TIMP-3 was up-regulated significantly under both un-loaded and
loaded conditions (Figure 2.3D). MMP-1 was up-regulated significantly with treatment
of IGF- 1 under un-loaded conditions, but was unaffected by the treatment of IGF- 1 when
loading conditions were present (Figure 2.3E).
Expression Trends and Groupings: After normalization of the data, using
principle component analysis (PCA), the 15 dimensional space was reduced to a three
dimensional space, by calculating three eigenvectors or principle components that
represent 80% of the variance in the data. With three principle components, each
standardized gene was projected in to the principle component space and can be
visualized as shown in figure 2.4. All 15 dimensions of each gene were used in the k-
means clustering technique to ensure that smaller gene variations were represented in the
grouping. After dividing the genes into 2 to 8 cluster groups and visually comparing the
distinctness of the groups, 5 groups appeared to be an adequate number of groupings
(Figure 2.4). These 5 groups contained 4 to 7 genes as shown in Table 2.2A. The mean
expression level is represented by a centroid (Figure 2.4) and the mean expression profile
of the 5 groups is shown in Figure 2.5.
Group 1 was significantly upregulated for all conditions and all time points
(Figure 2.5A). Under treatment of IGF-1, a 2-fold increase was observed at 24 hours and
under loading conditions a > 6-fold increase was observed at 24 hours as well. When
combining the treatment of IGF-I and compression, it appears the expression levels of
IGF-1 treatment dominate initially (2 hours). At 24 hours there appears to be an additive
effect of compression and IGF-1 treatment as the combined compression and IGF-1
levels are about 9-fold. (>6 + 2). At 32 and 48 hours, the effects of compression appear
to dominate the effects of IGF-1 treatment. Group 2 under treatment, compression, and
compression with treatment, are initially significantly upregulated, but return to control
expression levels at 48 hours (Figure 2.5B). In both compression and treatment
conditions, group 2 responds strongly by reaching > 3-fold and 2.5-fold respectively.
When IGF-1 treatment and compression are combined, all significantly upregulated time
points (2-32 hours) in treatment and compression are reduced with a peak value of 2-fold.
Under treatment conditions, with a strong significant up-regulated for the first three time
points, (peaked at > 3.5-fold) group 3 appears to be strongly upregulated by IGF-1
(Figure 2.5C). Under compression, group 3 has no significant initial changes, but at 48
hours in upregulated > 2-fold. When combining compression and treatment all time
points are reduced to control levels, apart from 24 hours, which is still significantly
upregulated, but reduced to 2-fold from > 3.5-fold in treatment alone. Group 4 under
IGF-1 treatment conditions is increasing significantly up-regulated until 32 hours (2.5-
fold) before it returns to near control levels at 48 hours (Figure 2.5D). Under
compression conditions, group 4 exhibits a near opposite effect as in the treatment
conditions, by initially being up-regulated ( 3-fold), and decreasing over time to return to
control levels. Previous data has shown that Aggrecan, a member of this group, acts in a
similar expression profile with a initial upregulation with compression followed by a
return to control levels [19]. Combining compression and treatment, no time points are
significantly different than control, but artifacts of the initial peak at 2 hours from
compression alone and peak at 32 hours from IGF-1 treatment alone appear. Group 5
showed very little change under IGF-1 treatment with a significant upregulation at 32
hours of 1.5-fold (Figure 2.5E). Under compression conditions, group 5 was upregulated
significantly at 2 and 8 hours with a peak of 1.6-fold, but by 24 hours until 48 hours was
significantly decreasingly down-regulated to a minimum point at 48 hours, loosing
greater than 50% expression compared to control. When combining compression and
IGF-1 treatment, all time points were lower than either compression or IGF-1 treatment
alone, and 24-48 hour were decreasingly down-regulated to a significant level, loosing
greater than 60% expression compared to control at 48 hours.
2.5 Discussion
To understand the transcriptional responses under different conditions, the 23
genes observed were clustered according to IGF-1 treatment alone, 50% static
compression alone, and the combination of static compression and IGF-1 treatment.
Lastly, to understand a more global view of transcriptional activity, all conditions and
time points were clustered together. The groupings assigned by clustering analysis can
be seen in Table 2.2A. Looking at the groupings under IGF-1 treatment alone, Link, type
II collagen, and aggrecan which were significantly upregulated, were grouped together,
while Txnip, the only molecule that was significantly down regulated by IGF-1 treatment
for multiple time points is uniquely grouped (Table 2.2B). Groupings of compression
alone isolate IL-6, highly non-responsive to compression over the time course measured,
in its own group. Transcription factors, highly initially upregulated genes, were grouped
together while transiently upregulated proteinases were allocated to a different grouped,
both of which support previous findings for compression (Table 2.2C) [19]. Examining
the combination of the treatments, Fibronectin was partitioned to a unique group for its
seemingly non-responsive behavior to compression and IGF-1 treatment. The majority
of proteinases were also grouped together (Table 2.2D). Looking at all three sets of
clusters, of note, MMP-1 and IGF-2 were grouped together under the three different
conditions, as well as link protein, and the components of the AP-1 complex, c-Fos and c-
Jun. Type II collagen and IGF-1, TIMP-3 and MMP-3, Sox-9 and TIMP-1 were
allocated in the same group for all three conditions. Compiling all conditions observed
into an expression vector, cluster analysis revealed that all cytokines were grouped
together, and were significantly upregulated under IGF-1 treatment alone compared to
controls. Under compression alone and IGF-1 and compression experiments this
extensive upregulation was not observed, suggesting that IGF-1 has a stimulatory effect
on cytokines which is mitigated when compression is present. Also of note, Aggrecan,
type II collagen, and link protein were all in separate groupings, suggesting that there
may be different mechanisms involved in the activation of these molecules. Of the
strongly upregulated group, transcription factors, growth factors, protease inhibitors, and
proteinases were grouped together, namely c-Fos, c-Jun, TGF-P, TIMP-3, MMP-3,
MMP-13, and ADAMTS-5.
With the 4 different sets of data clustered, (compression, IGF- 1, compression +
IGF-1, all conditions) three interesting pairings were always present: MMP-1 and IGF-2,
TIMP-3 and ADAMTS-5, type II collagen and IGF-1. MMP-1 or collagenase-1 is shown
to cleave key ECM molecules including collagen I, collagen II, aggrecan (at the MMP
cleavage site in the interglobular domain), fibronectin, and link protein [25]. MMP-l has
been shown to play a role in the regulation of paracrine signals, through the degradation
of cytokines such as IL-I1 [26]. Collagenase-1 has also been shown to degrade insulin-
like growth factor binding proteins (IGFBP) 3 and 5, which indirectly increases presence
of free (unbound) IGF [27, 28]. IGF-l and IGF-2 are known to bind IGFBP-3, the most
abundant IGF binding protein in human serum [29]. IGF-2 is known to stimulate DNA
and proteoglycan synthesis in chondrocytes [30] and has been shown to act in an
autocrine fashion [31]. IGF-2 has also been shown to stimulate type 1 IGF receptor, a
key receptor for IGF-I and also IGF-2 with lesser affinity [32, 33]. The co-expression of
MMP-1 and IGF-2 suggests that the two contain each other through their anabolic and
catabolic activities and have the capability of a strong anabolic response, due to the
stimulatory secondary effects of MMP- 1.
TIMPs act in a stochiometric fashion to reversibly inhibit metallo-proteinases
[34]. Of the four known TIMPs (1-4), TIMP-3 has been shown to be a strong inhibitor
of Aggrecanase-1 (ADAM-TS4) and Aggrecanase-2 (ADAM-TS5) with Ki values in the
subnanomolar range [35, 36]. When added exogenously to bovine nasal and porcine
articular cartilage, TIMP-3 retains the ability to inhibit aggrecanase activity induced by
catabolic factors [37]. In the current study, TIMP-3 is shown to be significantly
upregulated with the addition of IGF-1, and acts in a compression independent manner
(Figure 2.3). Although Aggrecan can be degraded by multiple members of the matrix
metalloproteinase family, it has recently been shown that ADAMTS-5 is the primary
aggrecanase responsible for aggrecan degradation in a murine model of osteoarthritis
[38]. The constant grouping based on expression profile of TIMP-3 and ADAMTS-5
suggests a biological control may present to ensure the turn over of aggrecan and the
regulation of anabolic and catabolic factors. Supporting these ideas, past clustering
analysis with cartilage under multiple conditions also grouped ADAMTS-5 and TIMP-3
together [19].
Type II Collagen, a key matrix protein, adds structure and strength to articular
cartilage. IGF-1 has been shown to elevate levels of type II collagen under a number of
different conditions [3, 10]. The co-expression of type II collagen and IGF-1 under
compressive and/or IGF-1 treated conditions suggests a positive feedback loop between
IGF-1 and type II collagen. Under IGF-1 treatment both are upregulated, while under
compression, both are down regulated. This supports previous data suggesting that IGF-1
acts in an autocrine fashion [1, 32]. Further studies using promoter analysis must be
performed to confirm if these pairings are co-expressed or if these results are an artifact
of the selected genes measured.
In contrast with previously published reports [3, 10, 11], the current results show
a slight upregulation of type II collagen in response to IGF-1 alone, compared to a
significant upregulation (Figure 2.2H). A possible explanation for the discrepancy in the
magnitude of type II collagen expression induced by IGF-1 was the 0% compression
control present in the current study, where free swell conditions were used in previously
published studies. Aggrecan was previously shown to have no significant change in the
first 48 hours [3], which this study supports (Figure 2.2F). Previously published data
show that MMP- 1, MMP-3, and MMP- 13 were unaffected by the addition of IGF- I after
48 hours, while the current data suggests a significant increase for 4 out of the 5 time
points in MMP-1 and MMP-13 (Figure 2.21, 2.2B). Again, reasons for this discrepancy
may be due to the 0% static compression present during IGF-1 treatment. IGF-1 mRNA
levels were maximum at 32 hours (Appendix A), where previous studies reported them to
peak at 24 hours [1]. Nixon et al. examined time points at 0, 4, 14, 24, 48, and 72 hours,
thus finding a maximum of 32 hours is not in direct contradiction to the previously
published finding. Sox-9 expression was shown to be significantly upregulated by IGF-1
at 4 of the 5 measured time points (2, 8, 32, 48), which previously was shown to be
unresponsive to IGF-1 at 72 hours (Appendix A). Many differences in the two
experiments exist possibly explaining the difference in IGF-1 response, i.e., bovine vs.
human, explant tissue vs. monolayer, 300 ng/mL IGF-1 vs. 100 ng/mL IGF-1.
In agreement with previously published data [13, 15, 18, 19], under static compression,
type II collagen and aggrecan were initially upregulated and then down regulated to
nearly control levels (Figure 2.2H, 2.2G).
Examining the transcriptional effects of IGF- 1 on aggrecan and link, IGF- I
appears to act via a compression-dependent manner (Figure 2.3A, 2.3C), whereas the
transcriptional effects of IGF-1 on collagen II and fibronectin appear to be independent of
compression (Figure 2.3F, Appendix B). This phenomenon could easily be explained by
the compacted ECM present under compression, dramatically restricting transport of
IGF-1 to chondrocytes. To test this idea, experiments were performed allowing IGF-1 to
be incubated for 24 hours (transport studies performed by Bonassar et al. [5]), to allow
IGF-1 to diffuse completely into the cartilage explant. Results of this experiment
replicate the trends seen in Figure 2.3A, 2.3C, suggesting that aggrecan and link act in a
compression-dependent manner when treated with IGF- 1. Whether this change is due to
decreased receptor-ligand affinity, or to mechanotransduction intracellular signaling
interference, remains to be determined.
At the transcriptional level, the current study points out the anabolic response due
to the treatment of IGF-1 under 0% compression loading, and the mixed anabolic and
catabolic signals under 50% static compression coupled with IGF-1. To further
investigate the transcriptional response to the protein synthesis under IGF-1 treatment
and compression, Figure 2.6 shows the levels of aggrecan protein synthesis, normalized
to 0% compression 0 IGF-1 compared to gene expression of aggrecan. Aggrecan gene
expression under 0% compression, 300 ng/ml IGF-1 is upregulated compared to control
for all 5 time points measured (Figure 2.6B). Examining the corresponding aggrecan
protein level at 0% compression, 300 ng/ml IGF-1, there is a strong increase in aggrecan
synthesis at 8, 24, and 48 hours (Figure 2.6A). These data suggest that aggrecan
synthesis is transcriptionally regulated by IGF-1. Examining the gene expression of
aggrecan under 50% compression 0 IGF-1, there is an initial bolus of transcript at early
time points, followed by a return to control levels (Figure 2.6B). Examining the protein
synthesis levels of aggrecan, at the same early time points, aggrecan synthesis is reduced
below control and this reduction is sustained for all time points measured, suggesting that
the inhibition of aggrecan synthesis by compression, with no IGF-1, is not
transcriptionally regulated (Figure 2.6A). Thus, in attempts to reconcile the
responsiveness of aggrecan under 50% static compression at the translational level with
the unresponsiveness of aggrecan at the transcriptional level, the authors support the
hypothesis [4] that under static compression, proteoglycan synthesis occurs through post-
transcriptional machinery.
2.6 Conclusion
Experiments have been performed to assess expression levels of a range of ECM
related genes in response to static loading in the presence and absence of IGF-1. Through
k-means clustering analysis, major co-expression trends were elucidated, grouping genes
into highly responsive, non-responsive, and differentially active gene profile groups. The
gene pairs MMP-1 and IGF-2, TIMP-3 and ADAMTS-5, and type II collagen and IGF-1
were consistently co-expressed in multiple clustering conditions, suggesting the
possibility of strong regulation and control relationships between members of each pair.
Aggrecan and link protein responded to IGF-1 in a compression-dependent manner,
whereas type II collagen and fibronectin appeared to respond to IGF-1 in a manner
independent of compression. While aggrecan transcripts were significantly upregulated
with the addition of IGF-1 under 0% compression, IGF-1 was unable to upregulate
aggrecan when the cartilage explants were statically compressed to 50% strain. In
comparing aggrecan gene expression to aggrecan synthesis, these data suggest that
aggrecan synthesis is transcriptionally regulated by IGF-1 while the inhibition of
aggrecan synthesis by compression is not transcriptionally regulated. However, more
studies are needed to elucidate the specific stimulatory mechanism(s) induced by IGF-1
and the post-translational inhibitory effects of compression.
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Figure 2.1. A schematic of the four conditions measured. 5 plugs were punched for each
time point and matched for time. IGF-1 treatment and static compression were applied at
time 0, and plugs were flash frozen at 2, 8, 24, 32, and 48 hours.
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Figure 2.2. Gene expression of proteinases, growth factors, and ECM molecules. 8
cartilage disks were pooled for each time point for each experiment. All genes were
normalized to 18s and plotted relative to 0% compression 0 IGF-1. Significance was
measured by the Wilcoxon sign ranked test compared to 0% compression 0 IGF-I (* p-
value <0.07). Mean + SE (n=4)
A MMP 3
**
50% Comp 0% Comp 50% Comp
0 IGF 300 IGF 300 IGF
TGF-B
** * *
*Y* kI#
U] ~~ El F 1
50%Comp 0%Comp 50%Comp
0 IGF 300 IGF 300 IGF
Aggrecan
- ---- -~---
**--
50% Comp 0% Comp
0 IGF 300 IGF
B MMP 13
**kj* __.. .. _..__ Jill
50% Comp 0% Comp 50% Comp
0 IGF 300 IGF 300 IGF
IGF-2
6
5
4
3
2
1
0
H
50% Comp
300 IGF
50% Comp 0% Comp 50% Comp
0 IGF 300 IGF 300 IGF
Collagen II
3
3 ~------ ---- "· -- ·----
52 ---
"5 . . . . . .
. . .... ..• _ . . . ..
50% Comp 0% Comp 50% Comp
0 IGF 300 IGF 300 IGF
TIMP-3
-. .- - ------- i-
50% Comp 0% Comp 50% Comp
0 IGF 300 IGF 300 IGF
Link Protein
•-- -/ -.- "- "A
. . . . . .. .. . . . . . . . . . . .. . . . . .. . . .
•· * J
50%Comp 0%Comp 50%Comp
0 IGF 300 IGF 300 IGF
MMP 1
Ki* *747
50% Comp np ,mp
0 IGF 300IGF 300IGF
M2hr M8hr Ei24hr =032hr f48hr
G
5
4
3
2
1
0
I:)
I
(-----------j
-- ~-~
I;---f :
:)
Figure 2.3. Effects of IGF-1. Gene expression was plotted normalized to like loading
condition in order to elucidate the effects of IGF-1 under compression or non-
compression. Aggrecan (A) and Link (C) respond to IGF-1 in a compression dependent
manner, while TIMP-3 (D) and Collagen II (F) respond to IGF-1 in a compression
independent manner. Significance was measured by the Wilcoxon sign ranked test
compared to like compression 0 IGF-1. (* p-value <0.07). Mean ± SE (n=4)
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Figure 2.4. Standardized gene expression visualized in principle component space.
Principle component 1, 2, and 3 represent 80% of the variance in the data. Genes were
allocated to one of five distinct groups by way of k-means clustering. Large solid black
circles denote the centroid of the corresponding group.
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Figure 2.5. Five expression profiles represent the combination of 0% compression 300
ng/ml of IGF-1, 50% compression 0 ng/ml of IGF-1, and 50% compression 300 ng/ml of
IGF-1. Centroid profiles were calculated through the average projection coordinates of
genes in each group, and transformed from principle component space through use of the
calculated principle components. Mean ± SE (n varies based on group component
number)
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Figure 2.6. Aggrecan Protein Synthesis compared to Aggrecan Gene Expression. (A)
Aggrecan protein synthesis as measured by 35S radiolabel incorporation normalized to
0% compression 0 IGF-1 adapted from Bonassar et al [5]. Mean plotted. (B) Aggrecan
gene expression normalized to 18s and plotted relative to 0% compression 0 IGF-1.
Significance was measured by the Wilcoxon sign ranked test compared to like
compression 0 IGF-1. (* p-value <0.07).
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Table 2.1. 24 Cartilage Relevant Genes. Primers were designed Primer3 software
(www.genome.wi.mit.edu/cgi-bin/primer/primer3www.cgi). Standard dilutions were
used to calculate relative mRNA copy number.
Protease Growth Transcription Stress Activated HousekeepingMatrix Molecules Proteases Cytokinesinhibitors Factors Factors Genes Gene
Type II Collagen MMP1 Timp-1 TNF-a IGF-1 c-Jun HSP90 18s
Aggrecan MMP3 Timp-2 IL-1 IGF-2 c-Fos Txnip
Link Protein MMP13 Timp-3 IL-4 TGF-B Sox-9
Fibronectin ADAMTS-5 IL-6
Table 2.2. Gene clustering groupings. Resulted gene sorting according to extent and
kinetics of expression. Specific gene allocation and centroid coordinates when all data
are clustered (A), 0% compression 300 ng/ml IGF-1 data clustered (B), 50%
compression 0 IGF-1 data clustered (C), and 50% compression 300 ng/ml IGF-1 data
clustered (D).
Centroid Coordinates
Group Genes (PC1, PC2, PC3)
1 TGF-B, c-Fos, c-Jun, Timp-3, ADAMTS-5, MMP13, MMP3 (-2.46, 2.37, -0.33)
2 Sox-9, HSP90, Timp-1, Link (-3.10, 0.95, -0.07)
3 TNF-a, IL-1, IL-4, IL-6 (-2.78, -1.50, -0.94)
4 IGF-2, MMP1, Fibronectin, Aggrecan (-2.71, -0.24, 2.03)
5 IGF-1, Txnip, Timp-2, Collagen II (0.32, 3.21, -0.19)
B
Centroid Coordinates
Group Genes (PC1, PC2, PC3)
1 TGF-B, Sox-9, Timp-2, Timp-1, Fibronectin (-1.81, 0.93, 0.43)
2 Txnip (1.11, 0.91, -1.55)
3 IGF-2, IGF-1, c-Jun, c-Fos, ADAMTS-5, MMP1, Link, Collagen II, Aggrecan (-2.05, 0.39, -0.25)
4 TNF-a, IL-6, IL-4, MMP13 (-1.48, -1.58, -0.22)
5 IL-1, HSP90, Timp-3, MMP3 (-2.03, -0.57, -0.05)
C
Centroid Coordinates
Group Genes (PC1, PC2, PC3)
1 IGF-1, Timp-2, Collagen II (0.44, 2.03, -0.13)
2 IGF-2, Txnip, MMP1, Fibronectin, Aggrecan (-1.41, 1.42, -0.48)
3 TNF-a, IL-4, IL-1, Timp-3, ADAMTS-5, MMP13, MMP3 (-1.92, 0.16, 0.56)
4 TGF-B, c-Jun, c-Fos, Sox-9, HSP-90, Timp-1, Link (-1.73, -0.86, -0.37)
5 IL-6 (0.59, -1.18, -1.76)
D
Centroid Coordinates
Group Genes (PC1, PC2, PC3)
IGF-2, MMP1
IL-6, IL-4, IL-1, Timp-3, ADAMTS-5, MMP13, MMP3
TGF-B, TNF-a, c-Jun, c-Fos, Sox-9, HSP90, Timp-1, Link
Fibronectin
IGF-1, Txnip, TIMP-2, Collagen II, Aggrecan
(-0.52, 0.62, -1.65)
(-1.88, -0.49, 0.14)
(-1.88, 0.62, 0.05)
(1.34, -1.62, -0.59)
(1.77, 0.70, 0.14)
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Cellular Events Leading to Chondrocyte Death After
Cartilage Impact Injury
D. M. Green,' P. C. Noble,' J. S. Ahuero,1 and H. H. Birdsall3
Objective. We undertook this study to test our
postulate that leukocytes extend the zone of injury in
cartilage after acute mechanical trauma.
Methods. Fresh cadaveric canine femoral con-
dyles were subjected to 20-25-MPa impact injury. Con-
dyle explants or dispersed chondrocytes were cultured
with autologous blood mononuclear leukocytes (MNLs).
Viability of chondrocytes at varying distances from the
impact site was assessed by trypan blue exclusion.
Results. Mechanical injury caused a significant
loss of viable chondrocytes over 7 days, even in cartilage
>10 mm from the impact site. After biomechanical
stress, death of cells within 10 mm of the impact could
be largely prevented by addition of N-;.monomethyl-L-
arginine to inhibit nitric oxide (NO) generation. Chon-
drocytes within 10 mm of the impact were also suscep-
tible to killing by living MNLs, but not by incubation
with the supernatants of endotoxin-activated MNLs.
Chondrocytes in this vulnerable zone expressed inter-
cellular adhesion molecule 1 (ICAM-1) (CD54), facili-
tating attachment of MNLs that localized adjacent to
the chondrocytes. Leukocytes killed dispersed chondro-
cytes harvested from the impact zone by generation of
reactive oxygen species. Leukocyte-mediated killing
could be blocked by desferoxamine or by antibodies to
CD)18, which prevent attachment of leukocytes to ICAM-
1-expressing chondrocytes.
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Conclusion. Our data suggest that after mechan-
ical injury, chondrocytes distant from the site may be
killed through the generation of NO. Inflammatory
leukocytes further extend the zone of chondrocyte death
by adhering to chondrocytes expressing ICAM-1 and by
inducing the accumulation of free oxygen radicals in the
chondrocyte cytoplasm. Patients may benefit from ther-
apies that reduce infiltration of inflammatory leuko-
cytes into acutely injured cartilage.
In vivo, human articular cartilage is repeatedly
subjected to peak stresses of up to 15-20 MPa (1). After
exposure to mechanical injury exceeding 20 MPa, up to
50% of chondrocytes die within 6-96 hours, principally
by apoptosis (2,3). Proteoglycans are also degraded in
the zone of injury (1,4), releasing glycosaminoglycans
into synovial fluids (5). Although it is well appreciated
that acute impact loading causes degeneration of artic-
ular cartilage via intracellular and extracellular pro-
cesses, the role of the inflammatory system in the
response of articular cartilage to mechanical trauma has
yet to be fully elucidated. Traumatic and ischemic injury
to parenchymal tissues typically stimulates an influx of
leukocytes (6). Even though their products may initially
exacerbate tissue injury, the infiltrating leukocytes ulti-
mately promote tissue regeneration and healing (7). The
situation may be different in cartilage. Considering the
limited regenerative potential of cartilage, tissue injury
caused by leukocytes might outweigh any reparative
phase they might direct.
When activated in vitro, cultured chondrocytes
release chemoattractants such as interleukin-8 (IL-8)
and monocyte chemoattractant protein 1 (MCP-1) that
direct the migration of leukocytes (8,9). Leukocytes, in
turn, are a source of proinflammatory cytokines, such as
IL-1 and tumor necrosis factor a (TNFa), that induce
apoptosis in both hypertrophic and nonhypertrophic
chondrocytes (10,11). IL-1 can also induce chondrocytes
to produce sufficient nitric oxide (NO) to cause cell
1509
GREEN ET AL
death (11). These proinflammatory cytokines up-
regulate the expression of intercellular adhesion mole-
cule 1 (ICAM-1) on chondrocytes, which allows the
attachment of leukocytes, and facilitate the accumula-
tion of toxic agents within the chondrocyte cytoplasm
(12). In addition, these cytokines stimulate the release of
metalloproteinases by injured chondrocytes and leuko-
cytes, and these metalloproteinases promote the degra-
dation of the extracellular matrix (10,13-18).
While it is clear that mediators released by
activated leukocytes can injure cultured and/or activated
chondrocytes in vitro (10,15-18), few studies have exam-
ined the effects of inflammatory cells on chondrocytes
embedded in their native matrix and activated by me-
chanical injury. Moreover, the mechanisms by which
inflammatory cells cause localized destruction of articu-
lar cartilage through direct interaction with chondro-
cytes are not fully understood. Using in vivo and in vitro
models, this study is the first to examine the mechanisms
of chondrocyte death after impact injury and the role of
leukocytes in extending the zone of injury to chondro-
cytes still resident in the articular matrix.
MATERIALS AND METHODS
Mechanical injury of condyles. Canine hind knee joints
were collected within 1 hour after death from 24 skeletally
mature young adult animals and sectioned, separating the
medial and lateral condyles. Each condyle was stored in 40 cc
of Dulbecco's phosphate buffered saline (DPBS) for no more
than 1 hour before being subjected to impact injury. Each
specimen was mounted beneath a drop weight impactor mod-
ified from the design of Thompson et al (19). An indentor,
consisting of a stainless steel rod of 6 mm diameter with a
0.5-mm rounded edge, was positioned perpendicular to the
surface of the articular cartilage. A 2-mm-thick piece of butyl
rubber was placed between the cartilage and the metallic tip to
distribute impact and prevent punch-out injury to the cartilage.
A sliding weight was used to strike the indentor, generating a
peak compressive stress of 20-25 MPa over a period of -10
msec. This stress has been determined by others to cause
reproducible cartilage injury (20). This system has also been
tested in an in vivo model and has been shown by magnetic
resonance imaging evaluation to create predictable osteochon-
drial injury (21).
Prior to impact injury, each condyle was mounted on a
metal plate at 30 degrees to the horizontal, and the indenting
rod was placed on a flat portion of the articular surface and
clamped in place. Three impacts were then delivered in rapid
succession. Because of the curvature of the condyle, the
30-degree angle allowed 2 sites to be impacted perpendicular
to the articular surface with minimal shear. After impacting 1
side of the condyle, the specimen was turned 180 degrees and
subjected to another series of 3 impacts. The condyle was then
divided in half between the impact sites and placed into fresh
DPBS. The left condyle remained uninjured and served as a
control, and was likewise divided into medial and lateral
halves. The impacted and control specimens were kept moist
during the experimental procedures, received the same length
of exposure on the test platform, and underwent the same
processing except for impact injury.
Culture of condyle explants. The condyle halves were
washed 3 times in 40 ml of DPBS, and the basal side was
irrigated to remove all macroscopic evidence of marrow. The
condyles were placed in 40 ml of RPMI 1640 with 10% fetal
calf serum (FCS) and 1% penicillin/streptomycin in a T-75
flask. This volume of medium was sufficient to completely
submerge the tissue and maintain the explants without acidi-
fication of the buffer. Samples were cultured in 5% CO 2 and
room air at 37"C. In some cases, condyles were cultured either
with autologous mononuclear leukocytes (MNLs) at a final
concentration of 1 x 105/ml or with the supernatant of
endotoxin-stimulated MNLs (20% [volume/volume]). In some
experiments, NG-methyl-L-arginine (L-NMA; Sigma, St. Louis,
MO) was added at a dose of 1 mM, which has been shown to
inhibit NO synthase in chondrocytes (22,23). Condyle explants
cultured with MNLs were gently rocked on a daily basis to
resuspend the MNLs.
Analysis of chondrocytes. After various intervals of 12
hours to 7 days, depending upon the experimental protocol,
specimens were removed from culture, and full-thickness
cartilage samples were harvested with a 4-mm biopsy punch
from 1) the area immediately contacted by the indentor (the
impact zone), 2) a site 6-9 mm from the edge of the impact
zone, and 3) a site at the periphery of the articular surface >10
mm from the impact zone. Samples were processed for histo-
logic analysis by frozen section or digested to harvest individual
chondrocytes. To disperse chondrocytes, cartilage was digested
in collagenase (2 mg/ml; Sigma) in complete medium (RPMI
1640 with 10% FCS and 1% penicillin/streptomycin) for 10
hours at 37"C in 5% CO2. Chondrocytes were harvested by
centrifugation at 1,100 revolutions per minute for 5 minutes
and transferred into complete medium. Cell viability was
assessed using trypan blue exclusion; a minimum of 100 cells
were counted in duplicate from each sample. Chondrocytes
were readily distinguished from leukocytes on the basis of size.
Each punch biopsy specimen yielded, on average, 5.62 ±
0.15 x 105 chondrocytes (mean t. SEM of 56 specimens), and
there were no significant differences in the total numbers of
chondrocytes recovered from biopsy samples obtained from
the different sites in the impacted condyles or from the
sham-treated condyles (P = 0.37 by Kendall's test).
Preparation of MNLs. Autologous blood was collected
into preservative-free heparin. MNLs, which include lympho-
cytes and monocytes, were isolated by density-gradient centrif-
ugation over Ficoll-Hypaque (Sigma) (24). Isolated MNLs
were washed in Ca 2` -free and Mg2+-free Hanks' buffered
saline (Life Technologies, Gaithersburg, MD) and then resus-
pended in complete medium at a concentration of 4 x 105/ml.
MNL viability was >95%. All reagents were nonreactive for
endotoxin by the Limuhlus amebocyte assay (Associates of Cape
Cod, Woods Hole, MA), which will detect as little as 0.03
endotoxin units/ml. MNLs were not activated by this isolation
protocol, since they have the same expression of L-selectin,
CD11b/CD18, and CD11a/CD18 as unseparated MNLs in
whole blood. MNLs were cultured in polypropylene tubes to
minimize subsequent monocyte isolation and/or loss through
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adherence to the culture vessel walls. Some MNLs were
stimulated with 1 gg/ml of Escherichia coli endotoxin (Sigma)
for 12 hours, and the supernatant, which contained the proin-
flammatory cytokines they released, was collected by centrifu-
gation.
Flow cytometric detection of adhesion molecules on
chondrocytes. Chondrocytes were suspended in complete me-
dium at 5 x 105/ml and incubated with Cell Tracker Green
(Molecular Probes, Eugene, OR) for 20 minutes at 370C to
identify viable cells (24). These cells were then washed with
DPBS, stained with mouse monoclonal antibody to canine
ICAM-1 (clone G-5; Santa Cruz Biotechnology, Santa Cruz,
CA) at 10 ng/sample for 30 minutes at 4°C, washed, and
stained with a phycoerythrin-conjugated goat anti-mouse anti-
body (Dako, Carpinteria, CA) for 30 minutes at 40C. Cells
were fixed in 1% paraformaldehyde and analyzed by flow
cytometry to assess the percent of viable chondrocytes express-
ing surface ICAM-1 (25). Delimiters on the flow cytometer
were set using cells stained in the same manner but with
nonspecific mouse immunoglobulin in lieu of anti-ICAM-1.
Immunohistochemical detection of adhesion mole-
cules on chondrocytes. For immunohistochemistry, tissues
were: mounted in OCT embedding compound and quick-
frozen. Five-micron sections were mounted on slides, fixed in
acetone for 4 minutes, then rinsed in water and PBS. Endog-
enous peroxides were blocked with 3% H20 2 for 30 minutes.
The sections were then rinsed and treated with 1% bovine
serum albumin for 15 minutes to block nonspecific staining.
Slides were stained with monoclonal anti-ICAM-1 (anti-
CD54) followed by biotinylated secondary rabbit anti-mouse
IgG and developed with avidin-biotin complex, diaminobenzi-
dine, and H20 2. Slides were then counterstained with hema-
toxylin to visualize nuclei.
Interactions of MNLs with chondrocytes. The condylar
explants were immersed in a suspension of MNLs at a final
concentration of 1 x 105/ml in complete medium. To aid in
identification, MNLs were prestained with a fluorescent green
dye (Cell Tracker Green) as previously described (24). After
12 hours, explants were dipped in medium to remove nonad-
herent leukocytes. Punch biopsy samples were obtained and
sectioned perpendicular to the cartilage surface. Sections were
examined with an inverted fluorescence microscope to identify
the location of MNLs that had adhered to the articular
cartilage.
Detection of oxidative species transferred to chondro-
cytes. Chondrocytes were released from collagenase-digested
cartilage biopsy samples 12 hours after injury and were then
incubated with 5- (and 6-)dichlorodihydrofluoresceindiacetate
(DCFDA; Molecular Probes) at a final concentration of 100
OM for 40 minutes at 370 C (26), washed twice, and suspended
in complete medium. DCFDA-labeled chondrocytes were
mixed with an equal number of MNLs (5 x 104 of each) in a
final volume of 200 p1 in a 96-well plate and incubated at 37°C.
Conversion of DCFDA to its oxidized fluorescent product was
detected with a fluorescence plate reader at 6 hours. In other
experiments, the incubation with leukocytes was extended to
72 hours, and viability was assessed by trypan blue exclusion.
To inhibit oxidative radicals, we used superoxide dismutase
(final concentration 200 units/ml; Sigma) or desferoxamine
(final concentration 0.1 mM; Sigma). Desferoxamine chelates
the iron that catalyzes the formation of hydroxyl radicals from
02- and H20 2. Superoxide dismutase inhibits the formation ofhydroxyl radicals by degrading 0 2-. When added to culture
medium, desferoxamine can diffuse into cells, but superoxide
dismutase cannot. To inhibit adhesion of leukocytes, we used
murine monoclonal anti-CD18 (R15.7; final concentration
50 /Lg/ml) (a gift from Dr. Wayne Smith, Baylor College of
Medicine). This antibody was incubated with MNLs for 30
minutes prior to their addition to chondrocytes.
Statistical analysis. Values are presented as the
mean ± SEM. Due to the small sample size, statistical
significance of differences between variables was calculated
using the nonparametric Mann-Whitney U test.
RESULTS
Viability of chondrocytes after mechanical in-
jury. Only 45 ± 3% of the chondrocytes from the
impacted zone were viable after 7 days in culture (P =
0.03; n = 4 dogs), compared with 92 ± 1% of chondro-
cytes from the uninjured controls (Figure 1). Chondro-
cyte viability was also significantly decreased in samples
taken 6-9 mm from the impact site (44 ± 2%) (P =
0.03) and even in samples taken >10 mm from the
impact site (60 ± 4%) (P = 0.03). The addition of
L-NMA to inhibit production of NO partially inhibited
chondrocyte death in the impact zone (P = 0.03) and
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Figure 1. Effect of mechanical injury on cartilage. Explants from
impact-injured and control uninjured condyles were cultured in me-
dium alone or in the presence of 1 mM Nc'-methyl-L.-arginine (L-
NMA). After 7 days, core biopsy samples were taken from the
uninjured condyle, at the impact site, within 6-9 mm of the impact, and
at a distant site >10 mm from the impact zone. Chondrocytes in the
biopsy samples were released by collagenase treatment, and their
viability was measured. Values are the mean ± SEM of data from 4
dogs. Impact injury led to significantly increased chondrocyte death in
all sampled sites, and this could be blocked to varying degrees by the
addition of L-NMA.
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completely prevented the death of cells >10 mm from
the impact site (P = 0.03) (Figure 1).
Effect of leukocytes on injured chondrocytes. To
evaluate the ability of leukocytes to extend the zone of
chondrocyte death after impact injury, we cultured
autologous peripheral blood MNLs (e.g., monocytes and
lymphocytes) with the cartilage explants for 7 days. In
the impact zone, chondrocyte viability dropped from
55 ± 3% in the absence of MNLs to 33 ± 6% when
cultured with MNLs (P = 0.0002; n = 8 dogs) (Figure 2).
In the zone adjacent to the impact, chondrocyte viability
dropped from 56 ± 4% in the absence of MNLs to 39 ±
8% when MNLs were present (P = 0.001). However, the
viability of chondrocytes located >10 mm from the
impact and that of chondrocytes from the unimpacted
control condyle were unaffected by coculture with
MNLs (P = 0.8 and P = 0.22, respectively). Chondrocyte
killing appeared to require living MNLs, because incu-
bation with the supernatants of endotoxin-activated
MNLs, which contained elevated levels of TNF and IL-1,
did not increase the numbers of nonviable chondrocytes
from any of the samples above those seen with medium
alone (data not shown).
MNL-chondrocyte interactions. To evaluate
which chondrocytes in injured cartilage provide chemo-
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Figure 2. Effect of mononuclear leukocytes (MNLs) on injured car-
tilage. Explants from impact-injured and control uninjured condyles
were cultured in medium alone or in the presence of autologous
MNLs. After 7 days, core biopsy samples were taken from the
uninjured condyle, at the impact site, within 6-9 mm of the impact, and
at a distant site >10 mm from the impact. Chondrocytes in the biopsy
samples were released by collagenase treatment, and their viability was
measured. Values are the mean + SEM of data from 8 dogs. Impact
injury led to chondrocyte death in all sampled sites. Incubation with
MNLs resulted in additional killing of chondrocytes at the site of
impact and within 9 mm of the impact.
Figure 3. Adherence of mononuclear leukocytes (MNLs) to injured
chondrocytes. Explants from impact-injured condyles were cultured
for 12 hours with autologous MNLs that had previously been labeled
with fluorescent green dye. Punch biopsy samples 4 mm in diameter
were taken from the impact site, washed by immersion in Dulbecco's
phosphate buffered saline to remove unattached leukocytes, and
sectioned for examination by microscopy. The figure shows the fluo-
rescent light image, to visualize the MNLs, superimposed on the
photomicrograph taken with incandescent light, to show the location of
the chondrocytes. The section is from the articular surface of the
cartilage. MNLs (green, single arrow) tended to localize immediately
adjacent to a chondrocyte (double arrow) (original magnification x
1,000).
tactic stimuli and adhesive ligands for MNLs, we incu-
bated the condyles with fluorescently tagged MNLs for
12 hours and examined thin cross-sections by fluores-
cence microscopy. MNLs adhered to cartilage explants
that had received an impact injury (Figure 3), but not to
uninjured cartilage explants (data not shown). The leu-
kocytes were not randomly distributed across the carti-
lage; instead, each leukocyte was located immediately
adjacent to a chondrocyte (Figure 3).
Expression of ICAM-1 on chondrocytes. Paren-
chymal cell expression of ICAM-1 (CD54) mediates the
attachment of leukocytes expressing counterreceptors
such as CDIla/CD18 (lymphocyte function-associated
antigen 1 [LFA-1]), CD11b/CD18, or CD11c/CD18. To
evaluate whether stress-injured chondrocytes express
ICAM-1, we harvested chondrocytes from explants after
24 hours in culture and used monoclonal antibodies to
identify ICAM-1-positive cells by flow cytometry (Fig-
ure 4A). Uninjured chondrocytes did not display any
ICAM-1. However, in the impact zone, 58 ± 7% of the
chondrocytes expressed ICAM-1 (P = 0.03; n = 4 dogs).
The fraction of chondrocytes expressing ICAM-1 de-
creased with distance from the impact site, with only
44 ± 4% ICAM-l-positive chondrocytes in the zone 6-
9 mm from the impact site (P = 0.03 versus uninjured
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Figure 4. Expression of intercellular adhe
on injured chondrocytes. Condyles were su
ex vivo; control condyles remained uninju
condyles were cultured for 24 hours, and
were taken from the uninjured condyle, at
mm of the impact, and at a distant site
Chondrocytes, released by collagenase, wer
ICAM-1 by flow cytometry. Bars show the
viable chondrocytes that expressed ICAM
formed in quadruplicate. B, Staining for IC
after impact injury to articular cartilage. AI
with hematoxylin to identify nuclei. Cells thL
arrow) are ICAM-1 positive; blue cells (d
negative. The majority of ICAM-1-positiv
25% of the articular cartilage (original ma
chondrocytes). In samples taken
impact site, only 7 ± 1% of the ch
ICAM-1. This value was significan
uninjured controls (P = 0.03),
lower than that in samples taken frt
site of impact (P = 0.03). To furthe
within the cartilage of chondrocyte
we examined sections by immu
hours after impact injury. The
chondrocytes were predominantly
A 25% of the articular cartilage and were uncommon in
the less superficial layers within the cartilage (Figure
4B).
Transmission of oxidative species from MNLs to
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tant of activated MNLs, were able to kill injured chon-
drocytes suggested a mechanism involving direct transfer
of toxic substances from the MNLs to the chondrocyte.
To evaluate whether MNLs transfer oxidative radicals to
the chondrocytes, we loaded the chondrocytes with a
cytoplasmic dye, DCFDA, which fluoresces when oxi-
dized. MNLs did not transfer oxidative radicals into
6-9mm from >10 mm control uninjured chondrocytes (P = 0.4) (Figure 5).
impact rroun impact However, if first injured by mechanical stress, DCFDA-
h .4 A I K -. lA .
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in fluorescence, indicative of oxidative damage, when
subsequently incubated with MNLs (P = 0.002; n = 6
dogs) (Figure 5). The increase in fluorescence was seen
-1-2 hours after addition of MNLs (data not shown)
and peaked at 6 hours.
To determine whether reactive oxygen species
(ROS) are transferred directly from the leukocyte to the
chondrocyte or merely released into the microenviron-
ment of the chondrocyte, we used a series of inhibitors
that block generation of hydroxyl radicals. Superoxide
dismutase, which cannot enter the cell cytoplasm, was
lnahlh, tn inhihit the inrrenas nf nvidntivp rndirnal in the
sion molecule 1 (ICAM-1) chondrocytes (P = 0.59). Desferoxamine, which canbjected to an impact injury
berted. A, Explants from the enter the cytoplasm, blocked the increase of oxidative
then core biopsy samples radicals in the chondrocytes (P = 0.002) (Figure 5).
the impact site, within 6-9 Addition of blocking antibodies to CD18, which prevent
>10 mm from the impact. the binding of leukocytes to ICAM-1-expressing chon-
*e assayed for expression of drocytes, also suppressed the increase of free oxygen
mean and SEM percent of
-1. Experiments were per- radicals in the chondrocytes, by 70 _ 6% (P = 0.009)
,AM-I expression 12 hours (Figure 5).
11 cells were counterstained To evaluate whether the transmission of ROS
at are stained brown (single was responsible for the leukocyte-mediated killing of
louble arrow) are ICAM-1 chondrocytes, we investigated the effects of these same
e cells are found in the topgnification the top00). blocking agents on viability of chondrocytes from im-
pacted cartilage. Impact injury alone caused 36 ± 2% of
the chondrocytes to die within 3 days. Addition of
>10 mm from the leukocytes increased the fraction of nonviable chondro-
Londrocytes expressed cytes to 70 ± 1%. Leukocyte-mediated injury was unaf-
tly higher than that in fected by superoxide dismutase (69 ± 1% nonviable
but also significantly chondrocytes) (P = 0.2). However, the additive effect of
om zones closer to the inflammatory leukocytes was fully blocked with des-
:r identify the location feroxamine (40 ± 1% nonviable chondrocytes) (P =
s expressing ICAM-1, 0.03) or L-NMA (42 ± 1% nonviable chondrocytes)
nohistochemistry 12 (P = 0.03) and was partially prevented by anti-CD18
ICAM-l-expressing antibodies, which block adherence of MNLs to ICAM-1
located within the top (48 ± 1% nonviable chondrocytes) (P = 0.03) (Figure 6).
. _
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Figure 5. Transfer of oxidative radicals from mononuclear leukocytes (MNLs) to injured chondrocytes.
Chondrocytes from the impact site or from uninjured condyles were released by collagenase treatment 12
hours after impact injury and loaded with an oxidation-sensitive fluorescent dye, 5- (and 6-)dichlorodi-
hydrofluoresceindiacetate. Chondrocytes were incubated with MNLs or medium alone for 6 hours. Bars
show the mean and SEM fold increase in fluorescence relative to chondrocytes incubated without MNLs
(n = 6 dogs). The transfer of oxidative radicals could be inhibited with desferoxamine or with blocking
antibodies to CD18, but not with superoxide dismutase (P = 0.59).
DISCUSSION
Our studies are the first to examine the fate of
chondrocytes after they are exposed to mechanical stress
while still resident within the cartilage. When articular
cartilage was exposed to an acute impact, approximately
half of the chondrocytes died within 7 days, whereas
>90% of the chondrocytes survived in uninjured carti-
lage. A surprising finding was the reduced viability of
chondrocytes located well outside the zone of direct
impact. Chondrocyte death at all sites was blocked by
Control carlilage
No MNL
MNIL &. medium
MNL. + superoxide dimulasc
MNL - desferoxaminc
MNL ÷ L-NMA
MNL + anti-CD l
L-NMA, an inhibitor of NO production (22,23). This
finding is consistent with those of others who have
demonstrated inhibition of apoptosis after NO blockade
with L-NMA in an arthritis model (27). The directly
impacted chondrocytes may have released NO, which
triggered apoptosis of distant chondrocytes. In addition,
the shock wave propagating from the epicenter of the
impact may have activated distant chondrocytes and
triggered production of NO.
Chondrocytes have shear stress response ele-
impactod catilage
50%·i I 0)L/,
S1.03
- i.031
50% 100%
% viable chondrocytes
Figure 6. Effect of oxidative radicals from mononuclear leukocytes (MNLs) on chondrocyte viability.
Chondrocytes from the impact-injured or uninjured condyles were released by collagenase treatment 12
hours after impact injury and incubated with medium or MNLs. After an additional 72 hours, chondrocyte
viability was assayed by trypan blue exclusion. Values are the mean and SEM (n = 6 dogs). Viability of
impact-injured chondrocytes was decreased in the presence of MNLs, and this could be prevented by the
addition of desferoxamine, NA-methyl-L-arginine (L-NMA), or anti-CD18, but not by the addition of
superoxide dismutase (P = 0.2).
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ments and are known to respond to biomechanical
signals by up-regulating matrix metalloproteinases and
proinflammatory cytokines (28,29). Clements et al dem-
onstrated that cyclical loading of cartilage at physiologic
peak stress levels causes apoptosis of cells both at the
site of compression and in an area immediately around
this site (30). In the present study, we examined cellular
events following discrete traumatic impact of osteochon-
dral specimens. The magnitude of the peak stresses
generated in the present study was several times larger
than that of those applied by Clements and coworkers.
High-impact injury may have a different signaling cas-
cade that makes chondrocytes susceptible to cell death
from NO; this requires further study.
Chondrocytes injured by impact became vulner-
able to further injury mediated by leukocytes. The
vulnerability of chondrocytes to leukocyte-mediated in-
jury was inversely proportional to the distance from the
impact site. This outcome could be explained by differ-
ential rates of ICAM-1 expression, since chondrocytes
within or immediately adjacent to the impact zone
expressed ICAM-1, whereas those distant from the site
of impact expressed very little ICAM-1, and no ICAM-1
was found on uninjured chondrocytes. ICAM-1 is an
adhesion molecule that can be displayed by diverse
somatic cells, particularly after injury or in the context of
inflammation. Leukocytes express receptors, CD11a/
CI)18 and CD11b/CD18, which allow them to attach to
target cells expressing ICAM-1. ICAM-1 was expressed
primarily by chondrocytes in the upper layer of the
cartilage. This is also where leukocytes adhered to the
chondrocytes. The role of ICAM-1 in the interaction of
leukocytes with injured chondrocytes was verified by
showing that in the presence of blocking antibodies to
CD18, the 3-chain common to both leukocyte receptors,
chondrocytes were no longer killed by leukocytes.
In this study, ICAM-1 expression was demon-
strated on chondrocytes as early as 12 hours after injury.
ICAM-1 has been demonstrated on isolated chondro-
cytes, cultured in vitro in the presence of proinflamma-
tory cytokines (12). However, this is the first time
up-regulation of ICAM-1 has been demonstrated after
acute mechanical injury of articular cartilage. In our
specimens, ICAM-:l was induced on injured chondro-
cytes even in the absence of MNLs, indicating that
leukocyte-derived factors were not required. ICAM-1I
was also found on chondrocytes that were not in the area
of the direct impact.
There are several possible mechanisms for injury
to chondrocytes distant from the direct site of impact.
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Previous studies have demonstrated that the ICAM-1
gene has a shear stress response element and that
endothelial cells exposed to flow-mediated shear stress
up-regulate their expression of ICAM-1 (31). During
localized impact of a joint surface, a shear wave propa-
gates through the cartilage and the underlying subchon-
dral bone. We hypothesize that this perturbation triggers
the shear stress response elements known to be present
within chondrocytes (32), and this intercellular signaling
event up-regulates ICAM-1. An alternative explanation
is that chondrocytes at the impact site released soluble
factors such as cytokines in response to mechanical
injury, which then stimulated nearby chondrocytes to
up-regulate ICAM-1. NO, for example, can initiate
intracellular signaling cascades leading to up-regulation
of cytokines (33). Basic fibroblast growth factor can also
be released from extracellular stores by mechanical
stress and activate the ERK signaling pathway, which
leads to a variety of proinflammatory responses (34).
The preferential influx of MNLs into injured, as
opposed to control, cartilage is probably mediated by
chemotactic factors released by the chondrocytes. Pre-
vious studies of inflammatory arthropathies and of car-
tilage stimulated with IL-1 in vitro have demonstrated
that 2 chemokines, MCP-1 and IL-8, are produced by
stimulated chondrocytes (8,9). MCP-1 is a highly potent
chemotactic factor for monocytes, and IL-8 is chemotac-
tic for neutrophils. It is likely that leukocytes have access
to impact-injured cartilage in vivo. We have found
lymphocytes, monocytes, and neutrophils in the synovial
fluid of dogs whose femoral condyles received an impact
injury similar to that applied to the explants in these
experiments (21). In the present study, we only evalu-
ated the adhesion of MNLs to the chondrocytes. Other
investigators have tested the ability of polymorphonu-
clear leukocytes to adhere to fragments of cartilage and
have found evidence of surface macromolecules that
block the adhesion of neutrophils (35).
Our studies show that leukocyte-mediated killing
of impact-injured chondrocytes involves ROS and/or
NO. The failure of superoxide dismutase, which remains
extracellular, to inhibit the oxidation of an indicator dye
in the chondrocyte cytoplasm indicates that the mecha-
nism does not involve release of ROS into the extracel-
lular milieu and subsequent uptake by the chondrocytes.
Inhibition by desferoxamine, which enters cytoplasm,
and by anti-CD18 antibodies, which block binding by
leukocyte adhesion molecules, is most consistent with a
model in which leukocytes adhere to chondrocytes and
transfer ROS directly into their cytoplasm. Such a
mechanism has been observed in other systems such as
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leukocyte-mediated killing of injured myocytes (36).
However, it is also possible that adherent leukocytes
induced the chondrocytes to generate ROS. NO and
ROS together can generate peroxynitrite (37), which is
highly toxic for chondrocytes (38,39). In our experi-
ments, cells were cultured in 5% CO 2 with room air,
which may best model processes occurring on the carti-
lage surface near the synovial fluid. Mechanisms of
injury for chondrocytes located more deeply in the
cartilaginous matrix may differ due to the lower oxygen
concentration in those sites (40-42).
Compared with medium alone, the supernatant
of endotoxin-stimulated MNLs, which contained TNFa,
IL-1, and IL-6, had no adverse effect on injured chon-
drocytes, suggesting that these cytokines are not respon-
sible for killing in this model. Our results suggest that
attachment to chondrocyte ICAM-1 mediated by leuko-
cyte CDlla/CD18 (LFA-1) or CDllb/CD18 brings leu-
kocytes into close apposition with the chondrocytes.
Indeed, as we have shown, treatment of cultured chon-
drocytes with antibodies to CD18 decreased accumula-
tion of free oxygen radicals in the chondrocytes by 70%.
ICAM-1/LFA-1-mediated cell death of chondrocytes
has been described previously (12), but this is the first
time that mechanical injury has been shown to cause
contact-mediated cell death of chondrocytes by inflam-
matory cells.
Our findings have possibly interesting clinical
implications. First, we have demonstrated that acute
mechanical injury of the articular surface causes death
of chondrocytes located at a distance from the site of
trauma. Second, up-regulation of adhesion molecules on
the affected chondrocytes allows leukocytes to adhere
and to extend the zone of injury beyond the impact site.
Thus, the data in this study suggest that therapies to
reduce acute influx of leukocytes into damaged cartilage
should be considered in the future when treating osteo-
chondral injuries.
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